Ftse Mib
34.127,62
-0,72%
DAX
19.906,08
-0,49%
S&P 500
5.942,47
1,26%
NASDAQ
19.621,68
1,77%
Bitcoin
98.327,85
0,12%
Pepperstone
Advertisement
Registration Strip Icon for discussion Registrati per interagire nei nostri forum attivi per discutere con investitori con idee simili.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni Regno Unito LSE Pharma Equity Group A/s (0REU) Pharma Equity Group A/s (0REU) Notizie

Pharma Equity Group A/s

0REU
0,40
0,00 (0,00%)
03 Gen 2025 - Chiuso
Dati in Delay di 15 minuti
Borsa: Londra
Tipo: Azione Ordinaria
Valuta: DKK

Ultime notizie

Data Ora Fonte Titolo
13/12/202412:21UKREGThe Board of Directors' decision on a new execution strategy..
29/11/202407:45UKREGMartin Engell-Rossen will be Head of Cabinet to Denmark's..
15/11/202408:32UKREGConsolidated Interim report 1 January – 30 September 2024
23/10/202410:28UKREGPharma Equity Group's subsidiary (Reponex Pharmaceuticals..
14/10/202408:17UKREGMajor shareholder announcement - Pharma Equity Group A/S
14/10/202407:59UKREGManagers’ transactions 
11/10/202408:37UKREGPharma Equity Group announces successful completion of..
04/10/202413:52UKREGPharma Equity Group announces issuance of new shares in a..
04/10/202409:01UKREGRegistration of capital reduction by way of a reduction of..
16/8/202408:52UKREGConsolidated Interim Report 1 January – 30 June 2024
16/7/202410:09UKREGThe Board of Directors' decision to issue convertible loans
15/7/202416:22UKREGMajor shareholder announcement - Pharma Equity Group A/S
15/7/202416:12UKREGMajor shareholder announcement - Pharma Equity Group A/S
03/6/202416:17UKREGResults of extraordinary general meeting in Pharma Equity..
16/5/202412:35UKREGThe Board of Director's decision to issue convertible loans
16/5/202407:27UKREGConsolidated interim report 1 January – 31 March 2024
08/5/202415:16UKREGExploration of options regarding a directed capital increase..
08/5/202410:20UKREGNotice convening the extraordinary general meeting of Pharma..
23/4/202411:45UKREGMajor shareholder announcement - Pharma Equity Group A/S
16/4/202417:29UKREGPassing of the General Meeting of Pharma Equity Group A/S
10/4/202414:21UKREGThe Board of Director's decision to issue convertible loans
05/4/202411:22UKREGPharma Equity Group’s subsidiary, Reponex Pharmaceuticals..
25/3/202413:06UKREGNotice convening the annual general meeting in Pharma Equity..
22/3/202409:00UKREGPharma Equity Group A/S (PEG) enters into an agreement with..
21/3/202416:32UKREGCompletion of subscription of convertible loans
20/3/202408:58UKREGPharma Equity Group A/S - Annual Report 2023
05/3/202410:11UKREGPharma Equity Group's subsidiary (Reponex Pharmaceuticals..
07/2/202413:38UKREGCompletion of subscription of convertible loans
07/2/202409:46UKREGThe Board of Director's decision to issue convertible loans
25/1/202410:08UKREGCompletion of subscription of convertible loans
22/1/202416:15GLOBENotification from the European Patent Office (EPO) regarding..
22/1/202415:54GLOBEThe Board of Director's decision to issue convertible loans
Apertura: Min: Max:
Chiusura: 0,40

La tua Cronologia

LSE
0REU
Pharma Equity Group A/s
LSE
0UGS
Alamos Gold
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network